HOME >> BIOLOGY >> NEWS
Early mammals used pelvic bones to trot, study finds

exactly like the fossils we have of mammals that lived millions of years ago," said Reilly, who has studied the evolution of animal locomotion for seven years. "We believe the earliest mammals probably moved just like the opossums because they're very similar anatomically."

Reilly and his collaborator Thomas White suspect that the development of epipubic bones made the prehistoric creatures more mobile. The increased locomotion made them better predators, helped them to escape predators and allowed them to forage more widely. "Locomotion contributed heavily to the evolution of mammals," Reilly said, "and these bones had something to do with increasing locomotor efficiency in the very earliest mammals."

As the mammals radiated after the dinosaurs went extinct, the epipubic bones in most mammals, including humans, became fused with the pelvis, which allowed mammals to use many gaits besides the trot.

The findings could have implications for paleontologists, Reilly said.

"If the function of the epipubic bone relates to locomotion, that makes the bones more important as a fossil indicator of increased locomotor efficiency," he said. If scientists study the fossil record and figure out when these bones first appeared, he added, it would shed light on a crucial step in the evolution of mammals.

The research is part of a larger study by Reilly and Ohio University colleague Audrone Biknevicius focusing on the evolution of locomotion, which is funded by a three-year, $295,000 National Science Foundation grant.


'"/>

Contact: Steve Reilly
reilly@ohio.edu
740-593-0424
Ohio University
16-Jan-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early treatment can prevent severe vision loss in premature infants
10. Early hominids may have behaved more human than we had thought
11. Early infection and rejection detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology:
Cached News: